Funding for this research was provided by:
Lung Cancer Proteomics
Received: 4 November 2019
Accepted: 11 February 2020
First Online: 21 February 2020
Ethics approval and consent to participate
: All samples were collected through an IRB approved protocol (e.g., Protocol #AST-FPB-003, Western IRB) or a signed Waiver of Consent form. Individuals under the age of 18 or those who cannot consent for themselves were not included in the study. Our manuscript does not contain any individual person’s data such as individual details, images or videos. All samples were collected in the United States between 2013 and 2015.
: All authors read and approved the final manuscript.
: C.G. and C.L.L. are consultants. T.L. serves as the Chief Executive Officer and Chief Financial Officer for Lung Cancer Proteomics LLC.